Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (OTHER 11 - 3) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 15, 2026 , from http://ppman.hank.ai/transparency/procedure/11 - 3/by-state?code_type=OTHER
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (OTHER 11 - 3) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/11 - 3/by-state?code_type=OTHER. Accessed
October 15, 2026 .
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (OTHER 11 - 3) by State,” HANK Price Transparency ,
accessed October 15, 2026 ,
http://ppman.hank.ai/transparency/procedure/11 - 3/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
11 - 3 — Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$201,473
National median
$201,473 – $463,632
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 11 - 3 (OTHER), with interquartile range
State Median p25 p75
NE $201,473 $201,473 $463,632